Tragusnervestimulation mod POTS efter COVID-19infektion
This is an AI summary of the abstract for “Prevalence of Covid-19 vaccine-induced thrombotic thrombocytopenia syndrome (VITT) in a high-risk population of patients with cancer: a prospective study.”
The study found a low prevalence of VITT in patients with cancer who received Covid-19 vaccination. This suggests that the benefits of vaccination outweigh the risks in this high-risk population. The study was published in the Journal of Clinical Oncology.
The method of the study involved prospectively monitoring patients with cancer who received the Covid-19 vaccine for the development of VITT. The results showed a low prevalence of VITT in this population, indicating that the benefits of vaccination in preventing Covid-19 outweigh the risks of potential side effects.
#Klinisk onkologi
Læs orginal abstract og artikel via Pubmed
*Disclaimer: AI baseret tekst, der har taget udgangspunkt i artiklen abstract. Teksten er derfor ikke egnet til at danne grundlag for fx. kliniske beslutninger. Tanken er snarere at give læseren lyst til at gå til kilde-teksten, og blive klogere.
